Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial
Options
BORIS DOI
Date of Publication
2012
Publication Type
Article
Division/Institute
Contributor
Raimann, Jochen G | |
Thijssen, Stephan | |
Kuntsevich, Viktoriya | |
Dabel, Pascal | |
Bachar, Mostafa | |
Diaz-Buxo, Jose A | |
Levin, Nathan W | |
Kotanko, Peter |
Series
Nephrology, dialysis, transplantation
ISSN or ISBN (if monograph)
0931-0509
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
21940484
Description
There is no agreement concerning dialyzate glucose concentration in hemodialysis (HD) and 100 and 200 mg/dL (G100 and G200) are frequently used. G200 may result in diffusive glucose flux into the patient, with consequent hyperglycemia and hyperinsulinism, and electrolyte alterations, in particular potassium (K) and phosphorus (P). This trial compared metabolic effects of G100 versus G200.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| gfr520.pdf | text | Adobe PDF | 188.78 KB | published |